VIENNA — AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. Read More
Source link
Iran receives 15-point ceasefire proposal from US, Pakistan officials say
Iran received a 15-point proposal from the U.S. to reach a ceasefire in the war, two Pakistani officials said Wednesday. The Pakistani officials described the proposal broadly as touching on…








